EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer - Wikidata - wikimedia - TriplyDB

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer

http://www.wikidata.org/entity/Q34365738

about

The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion Label-free enumeration, collection and downstream cytological and cytogenetic analysis of circulating tumor cells Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells.Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection EGFR-Based Immunoisolation as a Recovery Target for Low-EpCAM CTC Subpopulation.Cullin3 promotes breast cancer cells metastasis and epithelial-mesenchymal transition by targeting BRMS1 for degradation.Cross Talk Mechanism among EMT, ROS, and Histone Acetylation in Phorbol Ester-Treated Human Breast Cancer MCF-7 Cells.Role of Annexin A2 in the EGF-induced epithelial-mesenchymal transition in human CaSki cells.Circulating tumor cells in breast cancer beyond the genotype of primary tumor for tailored therapy.Phenotype of circulating tumor cell: face-off between epithelial and mesenchymal masks.Circulating tumor cell technologies.Epithelial-mesenchymal plasticity and circulating tumor cells: Travel companions to metastases.miRNA in situ hybridization in circulating tumor cells--MishCTC Epithelial-mesenchymal plasticity in circulating tumor cells.Epidermal Growth Factor Receptor Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated with Docetaxel Chemotherapy.Concordance between circulating tumor cells and clinical status during follow-up in anaplastic lymphoma kinase (ALK) non-small-cell lung cancer patients.A comprehensive study of circulating tumour cells at the moment of prostate cancer diagnosis: biological and clinical implications of EGFR, AR and SNPs.Cell-surface major vault protein promotes cancer progression through harboring mesenchymal and intermediate circulating tumor cells in hepatocellular carcinomas.Evaluation of serum epidermal growth factor receptor (EGFR) in correlation to circulating tumor cells in patients with metastatic breast cancer.Circulating Tumor Cells: Markers and Methodologies for Enrichment and Detection.Significance of EGFR Expression in Circulating Tumor Cells.Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients Inhibitor of DNA Binding 2 Inhibits Epithelial-Mesenchymal Transition via Up-Regulation of Notch3 in Breast Cancer

P2860

Q26741223-7C9192BE-04F6-4186-BE39-E52FE2EFFE79 Q28066285-10E9A5A8-6815-4E6C-9EAA-CC273C48C377 Q30822582-F25F1FD8-0C98-419C-8D96-E73439AFF93B Q35890322-95B364B8-572A-451F-AE7A-3D7BE6DA7B21 Q35935317-31EA6266-BE9A-4BCD-A23E-C89A7C7E7AFC Q36155201-8BF43933-4736-4E7C-943B-E3928656EF43 Q36561645-F2842C49-FE91-41C0-BDC4-279076F07C74 Q36795579-18AED451-837C-4169-BE25-90D553EA5622 Q37594006-49A975C9-0EB1-44DB-B54C-EDF38AA460C9 Q38547813-12C0F9B8-9B6A-4797-93F5-FA26735B1E59 Q38693785-47EAA1D6-55F8-4145-9303-6CC5D24B64A7 Q38742272-02B65AE8-1407-461B-9A28-AE2560794A25 Q38838108-7269C0F4-6D0A-494E-A029-6CEB44A5012B Q38899010-53FBDFBB-9411-4E34-B4B5-DC7AFBA1FD89 Q39053335-07C78A6E-5EF1-4111-B4E0-BC3C54CF5D0E Q39934173-0B509B03-998A-4148-AE06-9ECFA4CFAFA4 Q41708757-D5293F5D-8F2D-4F1F-A227-33802179F2A5 Q42378445-5B2BF765-037F-4728-A57A-4EEF27E10F32 Q42378979-A76E53B6-3D55-4FDB-9E2C-0537992A3562 Q47130842-DEFE3B92-FD65-4C6F-AD81-58E1892F9DA9 Q50199981-4123A53C-5D3B-4E46-81A0-B88397DDB9A6 Q50969676-26DC3681-4847-4BAA-8CDB-92A601719258 Q58761759-102B15A8-6C1C-4373-89DF-5D0A2019E89B Q58782071-6738159B-A5E1-4FF4-A9C1-3B4EC784E68B

P2860

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer

http://www.wikidata.org/entity/Q34365738

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer

@ast

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer

@en

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer

@nl

type

label

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer

@ast

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer

@en

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer

@nl

prefLabel

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer

@ast

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer

@en

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer

@nl

P1433

Q34365738-C3460C28-E3A1-44E6-93ED-C1F7206423A0

P1476

Q34365738-B2C563B7-39C9-4838-9E21-D704BA932B46

P2093

Q34365738-01D804AA-5553-4998-B6ED-3B050B589F62

Q34365738-172FC1FB-C9CD-49F5-83A3-21B99DF9AE46

Q34365738-4A7C2F18-A836-4333-B48A-9994E95557ED

Q34365738-A4EBA6A2-FC14-4982-8990-85F8B4996704

Q34365738-B39F0437-DC37-4841-AC2B-729DBC371942

Q34365738-BCD7FDBD-464C-4A74-9FFD-570895FF8451

Q34365738-BFA2391C-CB5C-41FE-8CA3-A554E0C7D0EA

Q34365738-C2A2B15F-E1C0-4302-A032-8DA17C19CF8D

Q34365738-D1C6B88D-6DBE-4BDC-A704-00CB6AA81A6B

Q34365738-DD87B2E9-27E8-4AA2-AC5B-BCF0EFBFFE1A

P2860

Q34365738-159E3E4F-E57D-47A2-922E-55BA485035A6

Q34365738-1FBEC4CC-3049-4E0A-917F-BAB99C6DAD9C

Q34365738-2DD52A2B-31AA-45E3-8529-104F14D69FD8

Q34365738-3BCDBDEC-186B-4E33-A787-BF96BC8CAA19

Q34365738-41EB3F29-45B6-45C6-9528-D0019D979BF9

Q34365738-45AD719F-84FC-4EC7-80AA-1614E7095EC9

Q34365738-4C9275CF-AED7-4784-A849-EB62E9789546

Q34365738-4F6AAA87-3027-4EA8-82EA-7BA495506011

Q34365738-5464503D-A2D7-4019-B56E-BA92BC9F85E6

Q34365738-6BC7FDC9-DA8C-4267-BF69-BF7605DFF30C

P304

Q34365738-0F645FAB-2420-4A44-BE1C-6C7502667AFD

P31

Q34365738-5CF2F8D5-B6F9-4ACA-83D7-A2183646C44C

P356

Q34365738-5D7437D6-821C-47D1-9373-015BA12DF74D

P407

Q34365738-A6CEA5C6-57F3-4971-8810-2DBB0A04D365

P433

Q34365738-9851C445-4F8E-4E11-8E90-CC2BFEC09CAB

P478

Q34365738-8D57B01F-4656-4C29-BB93-8C589FE30CAF

P50

Q34365738-035A21EB-F984-42D6-B131-7163E4B163AE

Q34365738-0371D5CD-98C3-48EC-9B51-357E56B3954D

Q34365738-197307E6-8330-499D-8D3D-69D40F328AC5

Q34365738-772462A2-1A15-4EEE-887E-59AF1845A158

P577

Q34365738-734ACBEE-742B-47A7-B27C-07861906617B

P5875

Q34365738-8C4D5680-484D-44AC-A105-430A0A65D7D3

P698

Q34365738-FE0BA93C-615B-42E5-9B7B-6836E67C5673

P932

Q34365738-CDE65914-3A73-45E6-B572-6BDB23D86A37

P356

ONCOTARGET.2217

P1433

P1476

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer

@en

P2093

Francisco G Ortega

http://www.w3.org/2001/XMLSchema#string

Francisco Solé

http://www.w3.org/2001/XMLSchema#string

Jose L García-Puche

http://www.w3.org/2001/XMLSchema#string

Maria A García

http://www.w3.org/2001/XMLSchema#string

Maria J Serrano

http://www.w3.org/2001/XMLSchema#string

Marta Salido

http://www.w3.org/2001/XMLSchema#string

María Rodríguez

http://www.w3.org/2001/XMLSchema#string

Miguel Delgado-Rodriguez

http://www.w3.org/2001/XMLSchema#string

Pedro Sanchez-Rovira

http://www.w3.org/2001/XMLSchema#string

Rafael Rosell

http://www.w3.org/2001/XMLSchema#string

P2860

Comprehensive molecular portraits of human breast tumours

The basics of epithelial-mesenchymal transition

Epithelial-mesenchymal transitions in tumour progression

Anoikis resistance: an essential prerequisite for tumor metastasis

Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition

Visualizing extravasation dynamics of metastatic tumor cells

Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancer

Loss of breast epithelial marker hCLCA2 promotes epithelial-to-mesenchymal transition and indicates higher risk of metastasis

Deconstructing the molecular portraits of breast cancer.

EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer

P304

7486-7497

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.2217

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Juan Antonio Marchal

José Antonio Lorente

María J Álvarez-Cubero

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266145158

http://www.w3.org/2001/XMLSchema#string

P698

25277187

http://www.w3.org/2001/XMLSchema#string

P932

4202138

http://www.w3.org/2001/XMLSchema#string